PMID- 34726381 OWN - NLM STAT- MEDLINE DCOM- 20220209 LR - 20220209 IS - 1944-8252 (Electronic) IS - 1944-8244 (Linking) VI - 13 IP - 45 DP - 2021 Nov 17 TI - Supramolecular Drug Delivery System from Macrocycle-Based Self-Assembled Amphiphiles for Effective Tumor Therapy. PG - 53564-53573 LID - 10.1021/acsami.1c14385 [doi] AB - Intelligent drug delivery systems (DDSs) that can improve therapeutic outcomes of antitumor agents and decrease their side effects are urgently needed to satisfy special requirements of treatment of malignant tumors in clinics. Here, the fabrication of supramolecular self-assembled amphiphiles based on the host-guest recognition between a cationic water-soluble pillar[6]arene (WP6A) host and a sodium decanesulfonate guest (G) is reported. The chemotherapeutic agent doxorubicin hydrochloride (DOX) can be encapsulated into the formed vesicle (G/WP6A) to construct supramolecular DDS (DOX@G/WP6A). WP6A affords strong affinities to G to avoid undesirable off-target leakage during delivery. Nanoscaled DOX@G/WP6A is capable of preferentially accumulating in tumor tissue via enhanced permeability and retention (EPR) effect. After internalization by tumor cells, the abundant adenosine triphosphate (ATP) binds competitively with WP6A to trigger the disintegration of self-assembled vesicles with the ensuing release of DOX. In vitro and in vivo research confirmed that DOX@G/WP6A is not only able to promote antitumor efficacy but also reduce DOX-related systemic toxicity. The above favorable findings are ascribed to the formation of ternary self-assembly, which profits from the combination of the factors of the EPR effect and the ATP-triggered release. FAU - Chen, Junyi AU - Chen J AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. AD - Key Laboratory of Inorganic-Organic Hybrid Functional Material Chemistry, Ministry of Education, Tianjin Key Laboratory of Structure and Performance for Functional Molecules, College of Chemistry, Tianjin Normal University, Tianjin 300387, P. R. China. FAU - Zhang, Yadan AU - Zhang Y AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Zhao, Liang AU - Zhao L AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Zhang, Yahan AU - Zhang Y AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Chen, Longming AU - Chen L AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Ma, Mengke AU - Ma M AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Du, Xinbei AU - Du X AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Meng, Zhao AU - Meng Z AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. FAU - Li, Chunju AU - Li C AUID- ORCID: 0000-0001-7450-4867 AD - Key Laboratory of Inorganic-Organic Hybrid Functional Material Chemistry, Ministry of Education, Tianjin Key Laboratory of Structure and Performance for Functional Molecules, College of Chemistry, Tianjin Normal University, Tianjin 300387, P. R. China. FAU - Meng, Qingbin AU - Meng Q AUID- ORCID: 0000-0001-8915-9509 AD - State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing 100850, P. R. China. LA - eng PT - Journal Article DEP - 20211102 PL - United States TA - ACS Appl Mater Interfaces JT - ACS applied materials & interfaces JID - 101504991 RN - 0 (Antibiotics, Antineoplastic) RN - 0 (Macrocyclic Compounds) RN - 0 (Macromolecular Substances) RN - 0 (Quaternary Ammonium Compounds) RN - 0 (Surface-Active Agents) RN - 0 (pillar(6)arene) RN - 80168379AG (Doxorubicin) SB - IM MH - Animals MH - Antibiotics, Antineoplastic/chemistry/*pharmacology MH - Cell Line MH - Cell Proliferation/drug effects MH - Cell Survival/drug effects MH - Doxorubicin/chemistry/*pharmacology MH - *Drug Delivery Systems MH - Drug Liberation MH - Drug Screening Assays, Antitumor MH - Humans MH - Liver Neoplasms, Experimental/drug therapy/pathology MH - Macrocyclic Compounds/chemistry/*pharmacology MH - Macromolecular Substances/chemistry/pharmacology MH - Mice MH - Mice, Nude MH - Molecular Structure MH - Quaternary Ammonium Compounds/chemistry/*pharmacology MH - Surface-Active Agents/chemical synthesis/chemistry/*pharmacology OTO - NOTNLM OT - chemotherapy OT - competitive release OT - drug delivery system OT - host-guest recognition OT - self-assembled amphiphile EDAT- 2021/11/03 06:00 MHDA- 2022/02/10 06:00 CRDT- 2021/11/02 12:10 PHST- 2021/11/03 06:00 [pubmed] PHST- 2022/02/10 06:00 [medline] PHST- 2021/11/02 12:10 [entrez] AID - 10.1021/acsami.1c14385 [doi] PST - ppublish SO - ACS Appl Mater Interfaces. 2021 Nov 17;13(45):53564-53573. doi: 10.1021/acsami.1c14385. Epub 2021 Nov 2.